Kursat Tigen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kursat Tigen has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Beste Ozben
Department of Cardiology, School of Medicine, Marmara University, Istanbul 34854, Türkiye
8 shared publications - Altug Cincin
Marmara University
5 shared publications - Emre Gürel
Marmara University
5 shared publications - Murat Sunbul
Marmara University
5 shared publications - Tuba Guctekin
Department of Cardiology, School of Medicine, Marmara University, Istanbul 34854, Türkiye
5 shared publications - Nurten Sayar
Marmara University
4 shared publications
Latest Publications
- Open Access
- 8 August 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (8) , 560
Atherogenic Index of Plasma in Relation to Angiographic Coronary Artery Disease Severity, Plasma Fatty Acid Composition, and Estimated Desaturase Activity: A Cross-Sectional Study
Background/Objectives: Conventional lipid parameters incompletely reflect coronary atherosclerotic burden, particularly in the setting of metabolic heterogeneity and residual cardiovascular risk. Composite indices such as the atherogenic index of plasma (AIP) and the triglyceride–glucose (TyG) index have emerged as integrative markers. Fatty acid desaturases regulate key pathways of lipid metabolism, and estimated desaturase activity indices (SCD-16, SCD-18, D5D, and D6D) may provide complementary information on the metabolic pathways underlying AIP and the TyG index. However, the relationships among composite atherogenic indices, plasma fatty acid composition, estimated desaturase activity indices, and coronary artery disease (CAD) severity remain incompletely understood. Methods: In this cross-sectional study, 61 patients undergoing coronary angiography for suspected CAD were evaluated. Coronary atherosclerotic burden was quantified using the Gensini score. AIP and the TyG index were calculated from fasting biochemical parameters. Plasma fatty acid composition was analyzed using gas chromatography–mass spectrometry, and estimated desaturase activity indices were calculated using product-to-precursor ratios. Results: AIP was independently associated with Gensini score (β = 37.020, p < 0.001), whereas the TyG index was not independently associated after adjustment for potential confounders (p = 0.101). In correlation analyses, AIP was positively correlated with HOMA-IR (ρ = 0.352, p < 0.05). Myristic acid was positively correlated with AIP, the TyG index, and VLDL (ρ = 0.297, 0.288, and 0.325, respectively; all p < 0.05), whereas n-6 polyunsaturated fatty acids were positively correlated with LDL (ρ = 0.276, p = 0.031). Among the estimated desaturase activity indices, D6D was positively correlated with AIP, BMI, insulin, and VLDL (ρ = 0.262, 0.376, 0.340, and 0.266, respectively; all p < 0.05), whereas D5D was inversely correlated with BMI and VLDL (ρ = −0.319 and −0.266, respectively; both p < 0.05). No significant associations were observed for SCD-16 or SCD-18. Conclusions: The observed associations between AIP, angiographic CAD severity, selected fatty acid species, and estimated desaturase activity indices suggest that AIP may provide complementary information regarding metabolic alterations associated with coronary atherosclerosis. These findings provide a basis for future studies exploring the relationship between composite atherogenic indices and fatty acid metabolism.
- 8 August 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (8) , 560
Open AccessAtherogenic Index of Plasma in Relation to Angiographic Coronary Artery Disease Severity, Plasma Fatty Acid Composition, and Estimated Desaturase Activity: A Cross-Sectional Study
Background/Objectives: Conventional lipid parameters incompletely reflect coronary atherosclerotic burden, particularly in the setting of metabolic heterogeneity and residual cardiovascular risk. Composite indices such as the atherogenic index of plasma (AIP) and the triglyceride–glucose (TyG) index have emerged as integrative markers. Fatty acid desaturases regulate key pathways of lipid metabolism, and estimated desaturase activity indices (SCD-16, SCD-18, D5D, and D6D) may provide complementary information on the metabolic pathways underlying AIP and the TyG index. However, the relationships among composite atherogenic indices, plasma fatty acid composition, estimated desaturase activity indices, and coronary artery disease (CAD) severity remain incompletely understood. Methods: In this cross-sectional study, 61 patients undergoing coronary angiography for suspected CAD were evaluated. Coronary atherosclerotic burden was quantified using the Gensini score. AIP and the TyG index were calculated from fasting biochemical parameters. Plasma fatty acid composition was analyzed using gas chromatography–mass spectrometry, and estimated desaturase activity indices were calculated using product-to-precursor ratios. Results: AIP was independently associated with Gensini score (β = 37.020, p < 0.001), whereas the TyG index was not independently associated after adjustment for potential confounders (p = 0.101). In correlation analyses, AIP was positively correlated with HOMA-IR (ρ = 0.352, p < 0.05). Myristic acid was positively correlated with AIP, the TyG index, and VLDL (ρ = 0.297, 0.288, and 0.325, respectively; all p < 0.05), whereas n-6 polyunsaturated fatty acids were positively correlated with LDL (ρ = 0.276, p = 0.031). Among the estimated desaturase activity indices, D6D was positively correlated with AIP, BMI, insulin, and VLDL (ρ = 0.262, 0.376, 0.340, and 0.266, respectively; all p < 0.05), whereas D5D was inversely correlated with BMI and VLDL (ρ = −0.319 and −0.266, respectively; both p < 0.05). No significant associations were observed for SCD-16 or SCD-18. Conclusions: The observed associations between AIP, angiographic CAD severity, selected fatty acid species, and estimated desaturase activity indices suggest that AIP may provide complementary information regarding metabolic alterations associated with coronary atherosclerosis. These findings provide a basis for future studies exploring the relationship between composite atherogenic indices and fatty acid metabolism.
- Open Access
- 23 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 260
Exploratory Analysis of Circulating GLP-1, GIP, and TMAO in Relation to Coronary Artery Disease Severity in Patients with Exertional Angina
Background/Objectives: The gut–heart axis has garnered increasing attention. Incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), along with trimethylamine N-oxide (TMAO), have been implicated in the pathogenesis of coronary artery disease (CAD). This study aimed to investigate associations between plasma levels of GLP-1, GIP, and TMAO and the severity of CAD, alongside their correlations with serum biochemical parameters and fatty acid composition. Methods: Sixty-one patients undergoing coronary angiography were evaluated and stratified by Gensini scores into normal-coronary-artery, moderate-CAD, or severe-CAD groups. Biochemical parameters in serum and plasma GLP-1, GIP, and TMAO levels were measured. Plasma fatty acid composition was analyzed. Results: Fasting plasma GLP-1 and TMAO levels were not associated with CAD severity. Although GIP showed associations with CAD severity, these were not retained after adjustment for age and sex. Plasma myristic acid levels were positively associated with Gensini score. GLP-1 correlated positively with saturated fatty acids and negatively with monounsaturated fatty acids. TMAO levels inversely correlated with n-3 polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid, and positively with the n-6/n-3 PUFA ratio, supporting its potential role in pro-atherogenic lipid profiles. Conclusions: These findings suggest complex associations between gut-derived metabolites, lipid metabolism, and CAD severity.
- 23 January 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (2) , 260
Open AccessExploratory Analysis of Circulating GLP-1, GIP, and TMAO in Relation to Coronary Artery Disease Severity in Patients with Exertional Angina
Background/Objectives: The gut–heart axis has garnered increasing attention. Incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), along with trimethylamine N-oxide (TMAO), have been implicated in the pathogenesis of coronary artery disease (CAD). This study aimed to investigate associations between plasma levels of GLP-1, GIP, and TMAO and the severity of CAD, alongside their correlations with serum biochemical parameters and fatty acid composition. Methods: Sixty-one patients undergoing coronary angiography were evaluated and stratified by Gensini scores into normal-coronary-artery, moderate-CAD, or severe-CAD groups. Biochemical parameters in serum and plasma GLP-1, GIP, and TMAO levels were measured. Plasma fatty acid composition was analyzed. Results: Fasting plasma GLP-1 and TMAO levels were not associated with CAD severity. Although GIP showed associations with CAD severity, these were not retained after adjustment for age and sex. Plasma myristic acid levels were positively associated with Gensini score. GLP-1 correlated positively with saturated fatty acids and negatively with monounsaturated fatty acids. TMAO levels inversely correlated with n-3 polyunsaturated fatty acids (PUFAs), particularly docosahexaenoic acid, and positively with the n-6/n-3 PUFA ratio, supporting its potential role in pro-atherogenic lipid profiles. Conclusions: These findings suggest complex associations between gut-derived metabolites, lipid metabolism, and CAD severity.
- 10 October 2025
- Published by Marmara University in Marmara Medical Journal
- Vol. 38 (3) , 204-208
The effect of influenza vaccine on arterial stiffness in young healthy adults
Objective: The arterial wall possesses a complex structure. Over time, arteries lose elasticity and become stiffer due to factors such as aging, chronic diseases, and increased inflammation. Pulse wave velocity (PWV) and augmentation index (AI) are widely recognized as direct markers of arterial stiffness. Previous studies have suggested a link between seasonal influenza infection and increased cardiovascular mortality. This study aimed to investigate the effects of influenza vaccination on arterial stiffness in healthy young adults. Patients and Methods: The study enrolled participants who received the influenza vaccine according to the latest guidelines. Prior to vaccination, participants completed the Hospital Anxiety and Depression Scale (HADS) to assess baseline mood and anxiety levels. Arterial stiffness was measured using an oscillometric device. After a 15-day follow-up, HADS assessments and arterial stiffness measurements were repeated. Results: A total of 48 participants were initially enrolled, and 33 who completed the follow-up were included in the final analysis. Statistically significant reductions were observed in systolic blood pressure (p
- 10 October 2025
- Published by Marmara University in Marmara Medical Journal
- Vol. 38 (3) , 204-208
The effect of influenza vaccine on arterial stiffness in young healthy adults
Objective: The arterial wall possesses a complex structure. Over time, arteries lose elasticity and become stiffer due to factors such as aging, chronic diseases, and increased inflammation. Pulse wave velocity (PWV) and augmentation index (AI) are widely recognized as direct markers of arterial stiffness. Previous studies have suggested a link between seasonal influenza infection and increased cardiovascular mortality. This study aimed to investigate the effects of influenza vaccination on arterial stiffness in healthy young adults. Patients and Methods: The study enrolled participants who received the influenza vaccine according to the latest guidelines. Prior to vaccination, participants completed the Hospital Anxiety and Depression Scale (HADS) to assess baseline mood and anxiety levels. Arterial stiffness was measured using an oscillometric device. After a 15-day follow-up, HADS assessments and arterial stiffness measurements were repeated. Results: A total of 48 participants were initially enrolled, and 33 who completed the follow-up were included in the final analysis. Statistically significant reductions were observed in systolic blood pressure (p
- Open Access
- 29 October 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (4) , 144-154
Machine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission
Background: Herein, we aimed to develop and test machine learning (ML) models to predict disease severity and/or progression in hospitalized COVID-19 patients through baseline laboratory features. Methods: In this retrospective study of hospitalized COVID-19 patients admitted to a tertiary care center, we evaluated routine admission data to determine the accuracy rates of different ML algorithms: k-nearest neighbor classifier, bagging classifier, random forest (RF), and decision tree. These models were compared over three outcomes: those who needed oxygen supplementation vs. who did not on admission (Analysis 1, n: 180), those who later developed oxygen requirement vs. those who did not (Analysis 2, n: 112), and those who needed invasive mechanical ventilation vs. those who did not during hospitalization (Analysis 3, n: 164). Results: The median age of the patients was 55 (44-68) years, with males constituting 47.2% of the subjects. At admission, 37.8% of the patients required oxygen supplementation. During hospitalization, 17.5% needed mechanical ventilation, and 8.3% died. For all analyses, RF had the highest accuracy in classifying the need for oxygen supplementation on admission (89.4%) or during hospitalization (91.1%) and for invasive mechanical ventilation (92.2%). These were followed by a bagging classifier for Analysis 1 (88.3%) and Analysis 3 (91.0%) and by a decision tree for Analysis 2 (88.4%). C-reactive protein, monocyte distribution width, and high-sensitive troponin-T were the most crucial laboratory contributors to Analysis 1, Analysis 2, and Analysis 3, respectively. Conclusion: Our study showed that ML algorithms could predict the need for oxygen supplementation and mechanical ventilation during hospitalization using baseline laboratory data, suggesting a slight superiority of RF, among others.
- 29 October 2024
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 6 (4) , 144-154
Open AccessMachine Learning to Predict Disease Severity and Progression in Hospitalized COVID-19 Patients Using Laboratory Data on Admission
Background: Herein, we aimed to develop and test machine learning (ML) models to predict disease severity and/or progression in hospitalized COVID-19 patients through baseline laboratory features. Methods: In this retrospective study of hospitalized COVID-19 patients admitted to a tertiary care center, we evaluated routine admission data to determine the accuracy rates of different ML algorithms: k-nearest neighbor classifier, bagging classifier, random forest (RF), and decision tree. These models were compared over three outcomes: those who needed oxygen supplementation vs. who did not on admission (Analysis 1, n: 180), those who later developed oxygen requirement vs. those who did not (Analysis 2, n: 112), and those who needed invasive mechanical ventilation vs. those who did not during hospitalization (Analysis 3, n: 164). Results: The median age of the patients was 55 (44-68) years, with males constituting 47.2% of the subjects. At admission, 37.8% of the patients required oxygen supplementation. During hospitalization, 17.5% needed mechanical ventilation, and 8.3% died. For all analyses, RF had the highest accuracy in classifying the need for oxygen supplementation on admission (89.4%) or during hospitalization (91.1%) and for invasive mechanical ventilation (92.2%). These were followed by a bagging classifier for Analysis 1 (88.3%) and Analysis 3 (91.0%) and by a decision tree for Analysis 2 (88.4%). C-reactive protein, monocyte distribution width, and high-sensitive troponin-T were the most crucial laboratory contributors to Analysis 1, Analysis 2, and Analysis 3, respectively. Conclusion: Our study showed that ML algorithms could predict the need for oxygen supplementation and mechanical ventilation during hospitalization using baseline laboratory data, suggesting a slight superiority of RF, among others.
- 28 January 2024
- Published by Marmara University in Marmara Medical Journal
- Vol. 37 (1) , 37-44
The effect of cardiac rehabilitation on left ventricular diastolic functions assessed by exercise stress echocardiography in patients with acute coronary syndrome
Objective: The aim of our study is to investigate the impact of cardiac rehabilitation on left ventricular (LV) diastolic function in acute coronary syndrome (ACS) patients. Patients and Methods: Patients were selected consecutively among ACS patients who underwent primary percutaneous intervention and were found eligible for cardiac rehabilitation program from May 2014 to May 2015. Forty-four patients were included in cardiac rehabilitation group and recruited to 30 sessions of Phase-3 cardiac rehabilitation program six weeks after discharge. Twenty consecutive patients were included as control group. LV diastolic functions were assessed by resting and stress echocardiography. Results: There were not any significant differences in characteristics between the groups. Resting and stress E velocities and resting lateral e’ velocity significantly increased after rehabilitation program. Left atrial volume index, resting and stress A velocities and average E/e’ ratios were significantly lower while stress lateral e’ velocity was significantly higher in rehabilitation group after program compared to controls. The number of patients with diastolic dysfunction decreased after rehabilitation program. Final resting and stress echocardiography revealed significantly lower frequency of diastolic dysfunction in rehabilitation group. Conclusion: Cardiac rehabilitation improves diastolic functions in ACS patients, which may be detected by stress echocardiography.
- 28 January 2024
- Published by Marmara University in Marmara Medical Journal
- Vol. 37 (1) , 37-44
The effect of cardiac rehabilitation on left ventricular diastolic functions assessed by exercise stress echocardiography in patients with acute coronary syndrome
Objective: The aim of our study is to investigate the impact of cardiac rehabilitation on left ventricular (LV) diastolic function in acute coronary syndrome (ACS) patients. Patients and Methods: Patients were selected consecutively among ACS patients who underwent primary percutaneous intervention and were found eligible for cardiac rehabilitation program from May 2014 to May 2015. Forty-four patients were included in cardiac rehabilitation group and recruited to 30 sessions of Phase-3 cardiac rehabilitation program six weeks after discharge. Twenty consecutive patients were included as control group. LV diastolic functions were assessed by resting and stress echocardiography. Results: There were not any significant differences in characteristics between the groups. Resting and stress E velocities and resting lateral e’ velocity significantly increased after rehabilitation program. Left atrial volume index, resting and stress A velocities and average E/e’ ratios were significantly lower while stress lateral e’ velocity was significantly higher in rehabilitation group after program compared to controls. The number of patients with diastolic dysfunction decreased after rehabilitation program. Final resting and stress echocardiography revealed significantly lower frequency of diastolic dysfunction in rehabilitation group. Conclusion: Cardiac rehabilitation improves diastolic functions in ACS patients, which may be detected by stress echocardiography.
- Open Access
- 1 January 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (6) , 319-327
The Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography
Right heart functions are affected in patients with bronchiectasis as a result of pulmonary hypertension induced by chronic hypoxemia. Pulmonary artery wall thickness has recently been introduced as a sign of intensive and prolonged inflammation. The aim of this study was to analyze right ventricular and right atrial functions and to mea-sure pulmonary artery wall thickness in patients with cystic fibrosis-bronch iecta sis in comparison to those with noncystic fibrosis-bronchiectasis and healthy individuals. We studied 36 patients with cystic fibrosis-bronchiectasis, 34 patients with noncystic fibrosis-bronchiectasis, and 32 age- and sex-matched control subjects. Lung function tests were performed. All subjects underwent comprehensive echocardiographic evaluation including conventional, tissue Doppler, speckle-tracking, and pulmonary artery wall thickness measurements. Right ventricular global longitudinal strain and global longitudinal right atrial strain during ventricular systole decreased in cystic fibrosis-bronchiectasis group compared with noncystic fibrosis-bronchiectasis and control groups (P <.001, both). Conversely, pulmonary artery wall thickness was increased in cystic fibrosis-bronchiectasis group in comparison to other groups (P <.001). Moreover, right ventricular global longitudinal strain was lower and pulmonary artery wall thickness was higher in patients with airflow obstruction (P <.001 and P =.025, respectively) than in those without. Only right ventricular global longitudinal strain was significantly correlated with pulmonary function test parameters. The negative effect of cystic fibrosis on right ventricular and right atrial functions was independent of age, gender, and disease duration. Our study showed that right ventricular and right atrial functions were deteriorated and pulmonary artery wall was thickened in cystic fibrosis-bronchiectasis patients more than noncystic fibrosis-bronchiectasis patients. Right ventricular global longitudinal strain detected subclinical right ventricular dysfunction and was associated with the severity of pulmonary disease.
- 1 January 2023
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 27 (6) , 319-327
Open AccessThe Impact of Cystic Fibrosis- and Noncystic Fibrosis-Bronchiectasis on Pulmonary Artery Wall Thickness and Right Heart Functions Assessed by Speckle-Tracking Echocardiography
Right heart functions are affected in patients with bronchiectasis as a result of pulmonary hypertension induced by chronic hypoxemia. Pulmonary artery wall thickness has recently been introduced as a sign of intensive and prolonged inflammation. The aim of this study was to analyze right ventricular and right atrial functions and to mea-sure pulmonary artery wall thickness in patients with cystic fibrosis-bronch iecta sis in comparison to those with noncystic fibrosis-bronchiectasis and healthy individuals. We studied 36 patients with cystic fibrosis-bronchiectasis, 34 patients with noncystic fibrosis-bronchiectasis, and 32 age- and sex-matched control subjects. Lung function tests were performed. All subjects underwent comprehensive echocardiographic evaluation including conventional, tissue Doppler, speckle-tracking, and pulmonary artery wall thickness measurements. Right ventricular global longitudinal strain and global longitudinal right atrial strain during ventricular systole decreased in cystic fibrosis-bronchiectasis group compared with noncystic fibrosis-bronchiectasis and control groups (P <.001, both). Conversely, pulmonary artery wall thickness was increased in cystic fibrosis-bronchiectasis group in comparison to other groups (P <.001). Moreover, right ventricular global longitudinal strain was lower and pulmonary artery wall thickness was higher in patients with airflow obstruction (P <.001 and P =.025, respectively) than in those without. Only right ventricular global longitudinal strain was significantly correlated with pulmonary function test parameters. The negative effect of cystic fibrosis on right ventricular and right atrial functions was independent of age, gender, and disease duration. Our study showed that right ventricular and right atrial functions were deteriorated and pulmonary artery wall was thickened in cystic fibrosis-bronchiectasis patients more than noncystic fibrosis-bronchiectasis patients. Right ventricular global longitudinal strain detected subclinical right ventricular dysfunction and was associated with the severity of pulmonary disease.
- Open Access
- 6 October 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (10) , 699-705
Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
Combination of dual antiplatelet therapy (DAPT) with glycoprotein (GP) IIb/IIIa inhibitors can increase bleeding risk. In this study, we aimed to investigate bleeding complications of different DAPTs with concomitant tirofiban use in patients with acute coronary syndrome (ACS). This retrospective study included 224 consecutive ACS patients (mean age 56.6±11.1 years, 193 men) who were given conventional dose of tirofiban (25 μg/kg per 3 minutes followed by an infusion of 0.15 μg/kg/min for 24 hours) in addition to DAPT (300 mg aspirin followed by 100 mg/day + 600 mg clopidogrel followed by 75 mg/day or 180 mg ticagrelor followed by 90 mg twice daily or 60 mg prasugrel followed by 10 mg/day). Any intra-hospital bleeding complications were noted. Of the 224 patients, 115 were given ticagrelor and 32 were given prasugrel. Mean hemoglobin fall was similar between the patients taking ticagrelor/prasugrel and those taking clopidogrel. Ten patients taking ticagrelor and one patient taking prasugrel had hemoglobin fall ≥3 g/dL versus two patients in clopidogrel group (p=0.228). Gastrointestinal bleeding (two patients taking ticagrelor), hematoma at access site (three patients taking ticagrelor), and cardiac tamponade (two patients taking ticagrelor) rates were also similar. Creatinine levels were associated with hemoglobin fall ≥3 g/dL (p=0.032, Odds ratio 2.189, 95% confidence interval 1.070–4.479). There was no relation between hemoglobin fall ≥3 g/dL and antiplatelet agent, age, sex, hypertension, or diabetes. Tirofiban may be given to patients receiving ticagrelor or prasugrel with a bleeding rate similar to clopidogrel. Close monitoring for bleeding risk is recommended, especially in patients with higher creatinine levels.
- 6 October 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (10) , 699-705
Open AccessBleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
Combination of dual antiplatelet therapy (DAPT) with glycoprotein (GP) IIb/IIIa inhibitors can increase bleeding risk. In this study, we aimed to investigate bleeding complications of different DAPTs with concomitant tirofiban use in patients with acute coronary syndrome (ACS). This retrospective study included 224 consecutive ACS patients (mean age 56.6±11.1 years, 193 men) who were given conventional dose of tirofiban (25 μg/kg per 3 minutes followed by an infusion of 0.15 μg/kg/min for 24 hours) in addition to DAPT (300 mg aspirin followed by 100 mg/day + 600 mg clopidogrel followed by 75 mg/day or 180 mg ticagrelor followed by 90 mg twice daily or 60 mg prasugrel followed by 10 mg/day). Any intra-hospital bleeding complications were noted. Of the 224 patients, 115 were given ticagrelor and 32 were given prasugrel. Mean hemoglobin fall was similar between the patients taking ticagrelor/prasugrel and those taking clopidogrel. Ten patients taking ticagrelor and one patient taking prasugrel had hemoglobin fall ≥3 g/dL versus two patients in clopidogrel group (p=0.228). Gastrointestinal bleeding (two patients taking ticagrelor), hematoma at access site (three patients taking ticagrelor), and cardiac tamponade (two patients taking ticagrelor) rates were also similar. Creatinine levels were associated with hemoglobin fall ≥3 g/dL (p=0.032, Odds ratio 2.189, 95% confidence interval 1.070–4.479). There was no relation between hemoglobin fall ≥3 g/dL and antiplatelet agent, age, sex, hypertension, or diabetes. Tirofiban may be given to patients receiving ticagrelor or prasugrel with a bleeding rate similar to clopidogrel. Close monitoring for bleeding risk is recommended, especially in patients with higher creatinine levels.
- Open Access
- 26 July 2021
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 1 (1)
Impact of Bi-ventricular systolic function on mortality in patients with sepsis and septic shock
Objectives: We aimed to evaluate left ventricular (LV) and right ventricular (RV) systolic performance in patients with sepsis or septic shock and possible functional alteration on in-hospital mortality. Patients and Methods: Thirty-seven consecutive patients with the diagnosis of sepsis or septic shock were included in the study. All patients underwent comprehensive transthoracic echocardiographic examination. Data of patients discharged from the intensive care unit was compared with data of patients who died in the hospital. Results: Fifteen patients (40.5%) survived, while 22 patients were died in the hospital (59.5%). A significant difference was detected between survivor and non-survivor groups regarding before discharge or death level of inflammatory markers such as CRP (p=0.05) and procalcitonin (p=0.03) besides BNP (p=0.01) and SOFA (p=0.009) score. There were two patients (5.4%) with EF value less than %50 in the study population. Eight patients (21.6%) displayed hypokinesia on the apical segment, and four patients (10.8%) had TAPSE values below 17 mm. One patient (6.6%) in the survivor group, but seven patients (31.8%) in the non-survivor group had apical hypokinesia with a trend towards significance (p=0.068). One patient in the survivor group (6.6%) and three patients (13.6%) in the non-survivor group had RV systolic dysfunction (p: 0.51). Conclusion: We found a much lower rate of LV and RV systolic dysfunction in patients with sepsis or septic shock compared with previous studies. None of the myocardial dysfunction types was associated with in-hospital mortality. Apical hypokinesia was also more prevalent in non-survivors despite borderline significance.
- 26 July 2021
- Published by Kosuyolu Heart Journal, Health Sciences University in Kosuyolu Heart Journal
- Vol. 1 (1)
Open AccessImpact of Bi-ventricular systolic function on mortality in patients with sepsis and septic shock
Objectives: We aimed to evaluate left ventricular (LV) and right ventricular (RV) systolic performance in patients with sepsis or septic shock and possible functional alteration on in-hospital mortality. Patients and Methods: Thirty-seven consecutive patients with the diagnosis of sepsis or septic shock were included in the study. All patients underwent comprehensive transthoracic echocardiographic examination. Data of patients discharged from the intensive care unit was compared with data of patients who died in the hospital. Results: Fifteen patients (40.5%) survived, while 22 patients were died in the hospital (59.5%). A significant difference was detected between survivor and non-survivor groups regarding before discharge or death level of inflammatory markers such as CRP (p=0.05) and procalcitonin (p=0.03) besides BNP (p=0.01) and SOFA (p=0.009) score. There were two patients (5.4%) with EF value less than %50 in the study population. Eight patients (21.6%) displayed hypokinesia on the apical segment, and four patients (10.8%) had TAPSE values below 17 mm. One patient (6.6%) in the survivor group, but seven patients (31.8%) in the non-survivor group had apical hypokinesia with a trend towards significance (p=0.068). One patient in the survivor group (6.6%) and three patients (13.6%) in the non-survivor group had RV systolic dysfunction (p: 0.51). Conclusion: We found a much lower rate of LV and RV systolic dysfunction in patients with sepsis or septic shock compared with previous studies. None of the myocardial dysfunction types was associated with in-hospital mortality. Apical hypokinesia was also more prevalent in non-survivors despite borderline significance.
- Open Access
- 30 April 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (5) , 294-303
Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment.
- 30 April 2021
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 25 (5) , 294-303
Open AccessTime delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment.
- Open Access
- 1 November 2017
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 32 (11) , 729-731
Correction of cortriatriatum sinister with classical Raghib's complex using an extracardiac conduit
We present a 32-year-old patient with cortriatriatum sinister with Raghib's complex (a left persistent superior vena cava draining into the left atrium with an absent coronary sinus and an atrial septal defect [ASD]) who underwent successful surgical correction with excision of the cortriatriatum, closure of the ASD, and establishing the drainage of the persistent left superior vena cava to the right atrium via interposition of an extracardiac 13-mm ringed polytetrafluoroethylene conduit.
- 1 November 2017
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 32 (11) , 729-731
Open AccessCorrection of cortriatriatum sinister with classical Raghib's complex using an extracardiac conduit
We present a 32-year-old patient with cortriatriatum sinister with Raghib's complex (a left persistent superior vena cava draining into the left atrium with an absent coronary sinus and an atrial septal defect [ASD]) who underwent successful surgical correction with excision of the cortriatriatum, closure of the ASD, and establishing the drainage of the persistent left superior vena cava to the right atrium via interposition of an extracardiac 13-mm ringed polytetrafluoroethylene conduit.